Please enable Javascript
Conferences
Expert Interviews
Roundtable
Mesothelioma
Non-Small Cell Lung Cancer
ALK+ NSCLC
EGFR+ NSCLC
EGFR+ NSCLC Learning Lab
Immunotherapy in NSCLC
KRAS+ NSCLC
Small Cell Lung Cancer
Menu
Robert E. Merritt, MD, MBA, FACS
Articles by Robert E. Merritt, MD, MBA, FACS
Guided by Data: Navigating Biopsies, Biomarkers, and Treatment Strategies in NSCLC
Ticiana Leal, MD
Expert Interviews
|
August 13, 2025
In the second segment of this roundtable series, the panel discusses the importance of safe sampling in biomarker testing.
View More
From Screening to Strategy: Navigating the First Steps in Lung Cancer Care
Ticiana Leal, MD
ASCO 2025
|
August 12, 2025
In the first segment of this roundtable series, the panel discusses the initial steps in NSCLC diagnosis and treatment.
View More
Sublobar Resection in Early-Stage NSCLC: Thoracic Surgeon Shares Insights From New Research
Robert E. Merritt, MD, MBA, FACS
Non-Small Cell Lung Cancer
|
February 7, 2025
Dr. Merritt shares new thoracic surgery research insights for patient selection in sublobar resection for early-stage NSCLC.
View More
Clinical Considerations Surrounding Sublobar Resection in NSCLC: Dr. Merritt Discusses Recent Review
Robert E. Merritt, MD, MBA, FACS
Non-Small Cell Lung Cancer
|
February 28, 2025
Robert E. Merritt, MD, MBA, FACS, shares insights on his systematic review of sublobar resection and lobectomy.
View More
Dr. Merritt on the Prognostic Value of SUVmax Change in the LCMC3 Study
Robert E. Merritt, MD, MBA, FACS
WCLC 2024
|
October 2, 2024
Robert E. Merritt, MD, MBA, FACS, discusses the analysis he presented at the IASLC 2024 World Conference on Lung Cancer.
View More